|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-3-31
|
|
pubmed:abstractText |
To perform a randomized study of the optimal timing of thoracic radiation (RT) as accelerated hyperfractionated radiation therapy (ACC HFX RT) in combination with concurrent chemotherapy (CHT) in limited-stage small-cell lung cancer (SCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
893-900
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9060525-Adult,
pubmed-meshheading:9060525-Aged,
pubmed-meshheading:9060525-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9060525-Carboplatin,
pubmed-meshheading:9060525-Carcinoma, Small Cell,
pubmed-meshheading:9060525-Combined Modality Therapy,
pubmed-meshheading:9060525-Etoposide,
pubmed-meshheading:9060525-Female,
pubmed-meshheading:9060525-Humans,
pubmed-meshheading:9060525-Lung Neoplasms,
pubmed-meshheading:9060525-Male,
pubmed-meshheading:9060525-Middle Aged,
pubmed-meshheading:9060525-Radiotherapy Dosage,
pubmed-meshheading:9060525-Survival Analysis
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
|
|
pubmed:affiliation |
Department of Oncology, University Hospital, Kragujevac, Yugoslavia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
